These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19215837)

  • 21. Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome.
    Mahida S; Derval N; Sacher F; Leenhardt A; Deisenhofer I; Babuty D; Schläpfer J; de Roy L; Frank R; Yli-Mayry S; Mabo P; Rostock T; Nogami A; Pasquié JL; de Chillou C; Kautzner J; Jesel L; Maury P; Berte B; Yamashita S; Roten L; Lim HS; Denis A; Bordachar P; Ritter P; Probst V; Hocini M; Jaïs P; Haïssaguerre M
    J Am Coll Cardiol; 2015 Jan; 65(2):151-9. PubMed ID: 25593056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. J wave elevation to monitor quinidine efficacy in early repolarization syndrome.
    Sacher F; Derval N; Horlitz M; Haïssaguerre M
    J Electrocardiol; 2014; 47(2):223-5. PubMed ID: 24332747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome.
    Belhassen B; Viskin S; Fish R; Glick A; Setbon I; Eldar M
    J Cardiovasc Electrophysiol; 1999 Oct; 10(10):1301-12. PubMed ID: 10515552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
    J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Dose Quinidine Effectively Reduced Shocks in Brugada Syndrome Patients with an Implantable Cardioverter Defibrillator: A Chinese Case Series Report.
    Shen T; Yuan B; Geng J; Chen C; Zhou X; Shan Q
    Ann Noninvasive Electrocardiol; 2017 Jan; 22(1):. PubMed ID: 27550400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Malignant fascicular ventricular tachycardia degenerating into ventricular fibrillation in a patient with early repolarization syndrome].
    Kane A; Defaye P; Jacon P; Mbaye A; Machecourt J
    Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):292-5. PubMed ID: 21665187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention.
    Das MK; Zipes DP
    J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of electrical storm with oral quinidine in Brugada syndrome.
    Bettiol K; Gianfranchi L; Scarfò S; Pacchioni F; Pedaci M; Alboni P
    Ital Heart J; 2005 Jul; 6(7):601-2. PubMed ID: 16274024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years.
    Siebermair J; Sinner MF; Beckmann BM; Laubender RP; Martens E; Sattler S; Fichtner S; Estner HL; Kääb S; Wakili R
    Europace; 2016 May; 18(5):718-25. PubMed ID: 26759124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug therapy for ventricular tachyarrhythmia in heart failure.
    Shiga T; Kasanuki H
    Circ J; 2007; 71 Suppl A():A90-6. PubMed ID: 17587746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infant case with a malignant form of Brugada syndrome.
    Suzuki H; Torigoe K; Numata O; Yazaki S
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1277-80. PubMed ID: 11083249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct Substrates of Idiopathic Ventricular Fibrillation Revealed by Arrhythmia Characteristics on Implantable Cardioverter-Defibrillator.
    Haïssaguerre M; Sellal JM; Benali K; de Becker B; Defaye P; Pascale P; Martins R; Mabo P; Xhaet O; Extramiana F; Surget E; Lavergne T; Marijon E; Adragao P; Carvalho MS; Milliez PU; Laredo M; Gandjbakhch E; Giustetto C; Gaita F; Tilz R; Jesel-Morel L; Steinfurt J; Arentz T; Knecht S; Duytschaever M; Roten L; Reichlin T; Fatemi M; Mansourati J; Kouakam C; Bessière F; Chevalier P; Tadros R; Macle L; Gallego F; Hadjis A; Sacher F; Pereira D; Hourdain J; Deharo JC; Eschalier R; Massoulié G; Maury P; Latcu DG; Anselme F; Duchateau J; Tixier R; Nademanee K; Nogami A; de Groot N; Vigmond E; Bernus O; Strik M; Bordachar P; Cathala A; Bouteiller X; Dubois R; Ploux S
    JACC Clin Electrophysiol; 2024 Sep; 10(9):1982-1994. PubMed ID: 38970599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoprenaline and quinidine to calm Brugada VF storm.
    Furniss G
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22891011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a Subcutaneous Implantable Cardioverter Defibrillator in a Child with Early Repolarization Syndrome.
    Taki M; Muraji S; Mori H; Nabeshima T; Toda K; Iwamoto Y; Masutani S; Kojima T; Yoshiba S; Kobayashi T; Sumitomo N
    Int Heart J; 2021 Jul; 62(4):919-923. PubMed ID: 34276004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
    Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
    Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.